Showing results (81-90 of 118) with videos related to
Sort By:
Pageof 12
JAMA Dermatology|November 14, 2019
Age-Specific Incidence of Melanoma in the United StatesKelly G Paulson, Deepti Gupta, Teresa S Kim, et al.Heliyon|January 4, 2024
Enhancing immunogenic responses through CDK4/6 and HIF2α inhibition in Merkel cell carcinomaJung Hyun Lee, Justin Daho Lee, Kelly Paulson, et al.Science Immunology|April 4, 2017
Tracking the Fate and Origin of Clinically Relevant Adoptively Transferred CD8+ T Cells In VivoAude G Chapuis, Cindy Desmarais, Ryan Emerson, et al.The Journal of Experimental Medicine|June 1, 2016
Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patientAude G Chapuis, Sylvia M Lee, John A Thompson, et al.Journal of Immunological Methods|December 31, 2020
Detection of engineered T cells in FFPE tissue by multiplex in situ hybridization and immunohistochemistryJocelyn H Wright, Li-Ya Huang, Stephanie Weaver, et al.Biorxiv : the Preprint Server for Biology|September 30, 2024
Overcoming immune evasion from post-translational modification of a mutant KRAS epitope to achieve TCR-T cell-mediated antitumor activityJihoon William Lee, Emily Y Chen, Taylor Hu, et al.AIDS (London, England)|September 21, 2000
Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapyP A Bart, G P Rizzardi, G Tambussi, et al.Cancer Immunology Research|March 18, 2020
Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8+ T Cells within Polyomavirus-Driven Merkel Cell CarcinomasLichen Jing, Mariliis Ott, Candice D Church, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
T-Cell Therapy Using Interleukin-21-Primed Cytotoxic T-Cell Lymphocytes Combined With Cytotoxic T-Cell Lymphocyte Antigen-4 Blockade Results in Long-Term Cell Persistence and Durable Tumor RegressionAude G Chapuis, Ilana M Roberts, John A Thompson, et al.Cancer Immunology Research|January 17, 2014
Regression of metastatic Merkel cell carcinoma following transfer of polyomavirus-specific T cells and therapies capable of re-inducing HLA class-IAude G Chapuis, Olga K Afanasiev, Jayasri G Iyer, et al.Pageof 12